Executive Function Disorders and Anxio-depressive Symptomatology in Children and Adolescents With Mitochondrial Pathologies

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

February 27, 2020

Study Completion Date

February 27, 2020

Conditions
Mitochondrial Diseases
Interventions
DIAGNOSTIC_TEST

Psychiatric assessment

"Psychiatric assessment and neuropsychological tests~* Test : Wechsler Intelligence Scale for Children (WISC-V)~* Test :Behavior Rating Inventory of Executive Function (BRIEF) : BRIEF-Parents, BRIEF-Teacher~* Global Assessment of Functioning Scale~* Scale : Brief Psychiatric Rating Scale (BPRS)~* Test : Children Depression Inventory (CDI)~* Scale : Revised-Children's Manifest Anxiety Scale (R-CMAS)~* Survey : Pediatric Quality of Life Inventory Version 4.0 (PedsQL™ 4.0)~* Scale : Conners' scale (parents and teachers)"

Trial Locations (1)

Unknown

Dr RIQUIN Elise, Angers

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT03832218 - Executive Function Disorders and Anxio-depressive Symptomatology in Children and Adolescents With Mitochondrial Pathologies | Biotech Hunter | Biotech Hunter